## RAYNE ROUCE

| | Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=JKQl4mDnIoj4CIrp9Q%3d%3d&rnd=4105935d-588f-40be-808b-9e2b33b68250)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=3010108)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=3010108&cachekey=c421fe2a-6382-40e8-b55a-0243d2376128)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Biography  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
awards and honors

2015| First Annual Immunooncology Young Investigator Forum Grant Award, Baylor
College of Medicine  
---|---  
2015 - 2018| Lymphoma Research Foundation Career Development Award, Baylor
College of Medicine  
2014| American Society for Blood and Marrow Transplantation Clinical Research
Training Course Scholar, Baylor College of Medicine  
2017 - 2018| Leukemia Texas Supportive Research Grant, Baylor College of
Medicine  
2016 - 2020| American Society of Hematology Career Development Award, Baylor
College of Medicine  
2016| NIH SPORE Developmental Research Award, 2016  
2018| Hurricane Harvey Hometown Hero (Houston Chronicle), 2018  
2019| Houston Business Journal Healthcare Hero (Outstanding Physician), 2019  
2020| BCM Department of Pediatrics Teaching Award: Best Grand Rounds, 2020  
2020| BCM Department of Pediatrics Research Mentorship Award, 2020  
2021| Outstanding Women in Science Award: The Association for Women in
Science, 2021  
2021| BCM Department of Pediatrics Young Investigator Award, 2021  
2023| American Society of Gene and Cell Therapy Award for Excellence in
Advancing Diversity, Equity and In  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Lamble AJ, Schultz LM, Nguyen K, [Hsieh EM](https://profiles.viictr.org/profile/22016567), McNerney K, **Rouce RH** , Gardner RA, Ghorashian S, Shah NN, Maude SL. Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults. Blood Adv. 2024 Jul 09; 8(13):3544-3548. PMID: [38701425](//www.ncbi.nlm.nih.gov/pubmed/38701425).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  2. Ma R, [Woods M](https://profiles.viictr.org/profile/31330385), [Burkhardt P](https://profiles.viictr.org/profile/31454204), Crooks N, [van Leeuwen DG](https://profiles.viictr.org/profile/31189489), Shmidt D, Couturier J, Chaumette A, Popat D, Hill LC, **Rouce RH** , Thakkar S, Orozco AF, Carisey AF, [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. Cell Rep Med. 2024 Jul 16; 5(7):101628. PMID: [38986621](//www.ncbi.nlm.nih.gov/pubmed/38986621).

Citations:  Fields:

Med Medicine (General)

  3. Mackall CL, Bollard CM, Goodman N, Carr C, Gardner R, **Rouce R** , Sotillo E, Stoner R, Urnov FD, Wayne AS, Park J, Kohn DB. Enhancing pediatric access to cell and gene therapies. Nat Med. 2024 Jul; 30(7):1836-1846. PMID: [38886624](//www.ncbi.nlm.nih.gov/pubmed/38886624).

Citations:  Fields:

Med Medicine (General)Mol Molecular Biology

  4. Gardner RA, White C, Elsallab M, Farnia S, Fraint E, [Grilley B](https://profiles.viictr.org/profile/266987), Bateman-House A, Grupp SA, Kenderian S, Locke FL, Nikiforow S, Oluwole OO, **Rouce RH** , Spiegel J, Shah NN, Sharma A, Komanduri K, Gill S. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 May 16. PMID: [38762057](//www.ncbi.nlm.nih.gov/pubmed/38762057).

Citations:  Fields:

Hem HematologyTra Transplantation

  5. Miller A, Daum R, Wang T, Wu M, Tat C, Pfeiffer T, [Navai S](https://profiles.viictr.org/profile/6714386), [Heczey A](https://profiles.viictr.org/profile/268789), [Hegde M](https://profiles.viictr.org/profile/270076), [Ahmed N](https://profiles.viictr.org/profile/268944), [Whittle SB](https://profiles.viictr.org/profile/3009971), Hill L, [Martinez C](https://profiles.viictr.org/profile/265827), [Krance R](https://profiles.viictr.org/profile/268199), [Ramos CA](https://profiles.viictr.org/profile/267038), **Rouce RH** , [Lulla P](https://profiles.viictr.org/profile/3010220), [Heslop HE](https://profiles.viictr.org/profile/269811), [Omer B](https://profiles.viictr.org/profile/3009902), Shekar M. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 May 08. PMID: [38819365](//www.ncbi.nlm.nih.gov/pubmed/38819365).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

  6. Talleur AC, Fabrizio VA, Aplenc R, Grupp SA, Mackall C, Majzner R, Nguyen R, Rouce R, Moskop A, McNerney KO, Talleur AC, Fabrizio VA, Aplenc R, Grupp SA, Mackall C, Majzner R, Nguyen R, **Rouce R** , Moskop A, McNerney KO. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults. Transplant Cell Ther. 2024 Jun; 30(6):565-579. PMID: [38588880](//www.ncbi.nlm.nih.gov/pubmed/38588880); PMCID: [PMC11139555](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11139555).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  7. Hill LC, **Rouce RH** , Wu MJ, Wang T, Ma R, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Smith TS, Yang L, Srinivasan M, [Burkhardt PM](https://profiles.viictr.org/profile/31454204), [Ramos CA](https://profiles.viictr.org/profile/267038), [Lulla P](https://profiles.viictr.org/profile/3010220), Arredondo M, [Grilley B](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 Mar 28; 143(13):1231-1241. PMID: [38145560](//www.ncbi.nlm.nih.gov/pubmed/38145560); PMCID: [PMC10997912](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10997912).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  8. Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, Rossoff J, Bonifant CL, Myers GD, **Rouce RH** , Toner K, Driscoll TA, Katsanis E, Salzberg DB, Schiff D, De Oliveira SN, Capitini CM, Pacenta HL, Pfeiffer T, Shah NC, Huynh V, Skiles JL, Fraint E, McNerney KO, Quigg TC, Krueger J, Ligon JA, Fabrizio VA, Baggott C, Laetsch TW, Schultz LM. Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023; 14:1239132. PMID: [37965315](//www.ncbi.nlm.nih.gov/pubmed/37965315); PMCID: [PMC10642031](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10642031).

Citations:  Fields:

All Allergy and Immunology

Translation:HumansCells

  9. [Badr H](https://profiles.viictr.org/profile/16943318), **Rouce R** , [Scheurer ME](https://profiles.viictr.org/profile/265805), [Lulla P](https://profiles.viictr.org/profile/3010220), Mims M, Reddy P. Bringing CAR T?cell therapy trials to underserved populations. Cancer Cell. 2023 12 11; 41(12):2007-2010. PMID: [37890490](//www.ncbi.nlm.nih.gov/pubmed/37890490); PMCID: [PMC11146682](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11146682).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  10. [Scherer LD](https://profiles.viictr.org/profile/22016570), **Rouce RH**. Targeted cellular therapy for treatment of relapsed or refractory leukemia. Best Pract Res Clin Haematol. 2023 09; 36(3):101481. PMID: [37612000](//www.ncbi.nlm.nih.gov/pubmed/37612000).

Citations:  Fields:

Hem Hematology

Translation:Humans

  11. Allen J, Berry D, Cook F, Hume A, **Rouce R** , Srirangam A, Wellman J, McCombs C. Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions. Mol Ther Methods Clin Dev. 2023 Jun 08; 29:513-521. PMID: [37287748](//www.ncbi.nlm.nih.gov/pubmed/37287748); PMCID: [PMC10242491](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10242491).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37287748/citedby/)

  12. Wayne AS, Huynh V, Hijiya N, **Rouce RH** , Brown PA, Krueger J, Kitko CL, Ziga ED, Hermiston ML, Richards MK, Baruchel A, Schuberth PC, Rossi J, Zhou L, Goyal L, Jain R, Vezan R, Masouleh BK, Lee DW. Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 2023 03 01; 108(3):747-760. PMID: [36263840](//www.ncbi.nlm.nih.gov/pubmed/36263840); PMCID: [PMC9973494](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9973494).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36263840/citedby/) Fields:

Hem Hematology

Translation:Humans

  13. **Rouce RH** , Nemecek E. Access offsets poverty in quest for CAR T cells. Blood. 2023 02 09; 141(6):558-560. PMID: [36757731](//www.ncbi.nlm.nih.gov/pubmed/36757731).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  14. Read JA, **Rouce RH** , Mo F, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [King KY](https://profiles.viictr.org/profile/269149). Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2023 03; 29(3):165.e1-165.e7. PMID: [36592718](//www.ncbi.nlm.nih.gov/pubmed/36592718); PMCID: [PMC9991966](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9991966).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:HumansAnimalsCells

  15. **Rouce RH** , [Scherer L](https://profiles.viictr.org/profile/22016570). Reverse translational studies inform dual-targeted CAR T-cell design. Blood. 2022 08 04; 140(5):409-410. PMID: [35925644](//www.ncbi.nlm.nih.gov/pubmed/35925644).

Citations:

  16. [Steffin DHM](https://profiles.viictr.org/profile/14348352), Muhsen IN, Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Ahmed N](https://profiles.viictr.org/profile/268944), [Hegde M](https://profiles.viictr.org/profile/270076), Wang T, Wu M, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Whittle SB](https://profiles.viictr.org/profile/3009971), [Lulla PD](https://profiles.viictr.org/profile/3010220), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), **Rouce RH** , [Heczey A](https://profiles.viictr.org/profile/268789), [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Grilley BJ](https://profiles.viictr.org/profile/266987), Robertson C, Torrano V, [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee AP](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: [35325065](//www.ncbi.nlm.nih.gov/pubmed/35325065); PMCID: [PMC9346960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9346960).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  17. Schultz LM, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, **Rouce RH** , Chinnabhandar V, Kunicki M, Barsan VV, Goksenin AY, Li Y, Mavroukakis S, Egeler E, Curran KJ, Mackall CL, Laetsch TW. Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. J Clin Oncol. 2022 03 20; 40(9):945-955. PMID: [34882493](//www.ncbi.nlm.nih.gov/pubmed/34882493); PMCID: [PMC9384925](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9384925).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34882493/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  18. Forbes LR, [Eckstein OS](https://profiles.viictr.org/profile/3010344), Gulati N, [Peckham-Gregory EC](https://profiles.viictr.org/profile/7520389), [Ozuah NW](https://profiles.viictr.org/profile/23479091), [Lubega J](https://profiles.viictr.org/profile/3009643), [El-Mallawany NK](https://profiles.viictr.org/profile/267714), [Agrusa JE](https://profiles.viictr.org/profile/6714452), [Vogel TP](https://profiles.viictr.org/profile/18883198), [Chaimowitz NS](https://profiles.viictr.org/profile/23496079), Rider NL, Mace EM, Orange JS, Caldwell JW, Aldave-Becerra JC, Jolles S, Saettini F, Chong HJ, Stray-Pedersen A, [Heslop HE](https://profiles.viictr.org/profile/269811), [Kamdar KY](https://profiles.viictr.org/profile/270282), **Rouce RH** , [Muzny DM](https://profiles.viictr.org/profile/268028), Jhangiani SN, [Gibbs RA](https://profiles.viictr.org/profile/269695), Coban-Akdemir ZH, [Lupski JR](https://profiles.viictr.org/profile/268099), [McClain KL](https://profiles.viictr.org/profile/266880), [Allen CE](https://profiles.viictr.org/profile/270283), [Chinn IK](https://profiles.viictr.org/profile/8065501), Poli MC. Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766. PMID: [34329649](//www.ncbi.nlm.nih.gov/pubmed/34329649); PMCID: [PMC8795244](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8795244).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34329649/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  19. [Vasileiou S](https://profiles.viictr.org/profile/22016531), [Lulla PD](https://profiles.viictr.org/profile/3010220), Tzannou I, Watanabe A, Kuvalekar M, Callejas WL, Bilgi M, Wang T, Wu MJ, [Kamble R](https://profiles.viictr.org/profile/265557), [Ramos CA](https://profiles.viictr.org/profile/267038), **Rouce RH** , Zeng Z, [Gee AP](https://profiles.viictr.org/profile/268378), [Grilley BJ](https://profiles.viictr.org/profile/266987), Vera JF, Bollard CM, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Leen AM](https://profiles.viictr.org/profile/268626), [Carrum G](https://profiles.viictr.org/profile/269657). T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425. PMID: [33507803](//www.ncbi.nlm.nih.gov/pubmed/33507803); PMCID: [PMC8274795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8274795).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33507803/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  20. [Hsieh EM](https://profiles.viictr.org/profile/22016567), **Rouce RH**. Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphoma. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):487-493. PMID: [33275669](//www.ncbi.nlm.nih.gov/pubmed/33275669); PMCID: [PMC7727550](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7727550).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33275669/citedby/) Fields:

Hem Hematology

Translation:Humans

  21. [Agrusa JE](https://profiles.viictr.org/profile/6714452), Scull BP, Abhyankar HA, Lin H, [Ozuah NW](https://profiles.viictr.org/profile/23479091), Chakraborty R, [Eckstein OS](https://profiles.viictr.org/profile/3010344), Gulati N, Fattah EA, [El-Mallawany NK](https://profiles.viictr.org/profile/267714), **Rouce RH** , [Dreyer ZE](https://profiles.viictr.org/profile/269653), [Brackett J](https://profiles.viictr.org/profile/265632), [Margolin JF](https://profiles.viictr.org/profile/268091), [Lubega J](https://profiles.viictr.org/profile/3009643), [Horton TM](https://profiles.viictr.org/profile/266755), Bollard CM, [Gramatges MM](https://profiles.viictr.org/profile/266349), [Kamdar KY](https://profiles.viictr.org/profile/270282), [McClain KL](https://profiles.viictr.org/profile/266880), [Man TK](https://profiles.viictr.org/profile/266960), [Allen CE](https://profiles.viictr.org/profile/270283). Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma. Cancers (Basel). 2020 Dec 02; 12(12). PMID: [33276546](//www.ncbi.nlm.nih.gov/pubmed/33276546); PMCID: [PMC7761312](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7761312).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33276546/citedby/)

  22. Pasquini MC, Hu ZH, Curran K, Laetsch T, Locke F, **Rouce R** , Pulsipher MA, Phillips CL, Keating A, Frigault MJ, Salzberg D, Jaglowski S, Sasine JP, Rosenthal J, Ghosh M, Landsburg D, Margossian S, Martin PL, Kamdar MK, Hematti P, Nikiforow S, Turtle C, Perales MA, Steinert P, Horowitz MM, Moskop A, Pacaud L, Yi L, Chawla R, Bleickardt E, Grupp S. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 2020 11 10; 4(21):5414-5424. PMID: [33147337](//www.ncbi.nlm.nih.gov/pubmed/33147337); PMCID: [PMC7656920](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7656920).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33147337/citedby/) Fields:

Hem Hematology

Translation:Humans

  23. [Hsieh EM](https://profiles.viictr.org/profile/22016567), [Scherer LD](https://profiles.viictr.org/profile/22016570), **Rouce RH**. Replacing CAR-T cell resistance with persistence by changing a single residue. J Clin Invest. 2020 06 01; 130(6):2806-2808. PMID: [32364534](//www.ncbi.nlm.nih.gov/pubmed/32364534); PMCID: [PMC7260020](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7260020).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32364534/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  24. **Rouce RH**. The earlier the better: timely mitigation of CRS. Blood. 2019 12 12; 134(24):2119-2120. PMID: [31830277](//www.ncbi.nlm.nih.gov/pubmed/31830277).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31830277/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  25. [Lapteva N](https://profiles.viictr.org/profile/269143), Gilbert M, Diaconu I, [Rollins LA](https://profiles.viictr.org/profile/28998998), Al-Sabbagh M, Naik S, [Krance RA](https://profiles.viictr.org/profile/268199), Tripic T, Hiregange M, Raghavan D, Dakhova O, **Rouce RH** , Liu H, [Omer B](https://profiles.viictr.org/profile/3009902), Savoldo B, Dotti G, Cruz CR, Sharpe K, Gates M, Orozco A, Durett A, Pacheco E, [Gee AP](https://profiles.viictr.org/profile/268378), [Ramos CA](https://profiles.viictr.org/profile/267038), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355). T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells. Clin Cancer Res. 2019 12 15; 25(24):7340-7350. PMID: [31558475](//www.ncbi.nlm.nih.gov/pubmed/31558475); PMCID: [PMC7062259](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7062259).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31558475/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  26. [Gruner SE](https://profiles.viictr.org/profile/269355), Sayeed H, Suarez-Ferguson L, Perez C, **Rouce R** , [Fisher KE](https://profiles.viictr.org/profile/8451894), [Rau RE](https://profiles.viictr.org/profile/270060). Ponatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations. Pediatr Hematol Oncol. 2019 11; 36(8):514-519. PMID: [31510844](//www.ncbi.nlm.nih.gov/pubmed/31510844).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31510844/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  27. [Quach DH](https://profiles.viictr.org/profile/3010661), Becerra-Dominguez L, **Rouce RH** , [Rooney CM](https://profiles.viictr.org/profile/268355). A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells. J Transl Med. 2019 07 24; 17(1):240. PMID: [31340822](//www.ncbi.nlm.nih.gov/pubmed/31340822); PMCID: [PMC6657103](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6657103).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31340822/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  28. [Steffin DHM](https://profiles.viictr.org/profile/14348352), [Hsieh EM](https://profiles.viictr.org/profile/22016567), **Rouce RH**. Gene Therapy: Current Applications and Future Possibilities. Adv Pediatr. 2019 08; 66:37-54. PMID: [31230699](//www.ncbi.nlm.nih.gov/pubmed/31230699).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31230699/citedby/) Fields:

Ped Pediatrics

Translation:Humans

  29. Sharma S, **Rouce RH**. Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine. J Clin Invest. 2019 04 15; 129(5):1836-1838. PMID: [30985295](//www.ncbi.nlm.nih.gov/pubmed/30985295); PMCID: [PMC6486379](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6486379).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30985295/citedby/) Fields:

Med Medicine (General)

Translation:HumansCellsPHPublic Health

  30. Atilla E, Atilla PA, Mo F, Tashiro H, Srinivasan M, [Lulla P](https://profiles.viictr.org/profile/3010220), **Rouce RH** , [Ramos CA](https://profiles.viictr.org/profile/267038), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306), Gomes-Silva D, Cabral JMS. CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia. Mol Ther. 2019 01 02; 27(1):272-280. PMID: [30391141](//www.ncbi.nlm.nih.gov/pubmed/30391141); PMCID: [PMC6318703](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6318703).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30391141/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  31. McLaughlin LP, **Rouce R** , [Gottschalk S](https://profiles.viictr.org/profile/270181), Torrano V, [Carrum G](https://profiles.viictr.org/profile/269657), Wu MF, Hoq F, [Grilley B](https://profiles.viictr.org/profile/266987), Marcogliese AM, Hanley PJ, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 2018 11 29; 132(22):2351-2361. PMID: [30262660](//www.ncbi.nlm.nih.gov/pubmed/30262660); PMCID: [PMC6265652](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6265652).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30262660/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  32. [Ramos CA](https://profiles.viictr.org/profile/267038), **Rouce R** , Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Wu MF, Liu H, [Grilley B](https://profiles.viictr.org/profile/266987), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Savoldo B, Dotti G. In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas. Mol Ther. 2018 12 05; 26(12):2727-2737. PMID: [30309819](//www.ncbi.nlm.nih.gov/pubmed/30309819); PMCID: [PMC6277484](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6277484).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30309819/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  33. [Doherty E](https://profiles.viictr.org/profile/14348409), **Rouce RH**. Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML. Biol Blood Marrow Transplant. 2018 08; 24(8):1533-1535. PMID: [29933070](//www.ncbi.nlm.nih.gov/pubmed/29933070).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29933070/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  34. Tashiro H, Sauer T, Shum T, Parikh K, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), **Rouce RH** , [Lulla P](https://profiles.viictr.org/profile/3010220), [Rooney CM](https://profiles.viictr.org/profile/268355), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200). Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213. PMID: [28676343](//www.ncbi.nlm.nih.gov/pubmed/28676343); PMCID: [PMC5589064](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589064).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28676343/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  35. [Rezvani K](https://profiles.viictr.org/profile/12583611), **Rouce R** , Liu E, [Shpall E](https://profiles.viictr.org/profile/12582631). Engineering Natural Killer Cells for Cancer Immunotherapy. Mol Ther. 2017 08 02; 25(8):1769-1781. PMID: [28668320](//www.ncbi.nlm.nih.gov/pubmed/28668320); PMCID: [PMC5542803](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5542803).

Citations:
[161](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28668320/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  36. **Rouce RH** , [Heslop HE](https://profiles.viictr.org/profile/269811). Equal opportunity CAR T cells. Blood. 2017 06 22; 129(25):3275-3277. PMID: [28642356](//www.ncbi.nlm.nih.gov/pubmed/28642356); PMCID: [PMC5482104](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5482104).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28642356/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  37. Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, [Wagner DL](https://profiles.viictr.org/profile/45193203), Davis TH, **Rouce RH** , Bao G, [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017 07 20; 130(3):285-296. PMID: [28539325](//www.ncbi.nlm.nih.gov/pubmed/28539325); PMCID: [PMC5520470](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5520470).

Citations:
[131](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28539325/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  38. **Rouce RH** , Sharma S, Huynh M, [Heslop HE](https://profiles.viictr.org/profile/269811). Recent advances in T-cell immunotherapy for haematological malignancies. Br J Haematol. 2017 03; 176(5):688-704. PMID: [27897332](//www.ncbi.nlm.nih.gov/pubmed/27897332); PMCID: [PMC5318250](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5318250).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27897332/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  39. **Rouce RH** , [Heslop HE](https://profiles.viictr.org/profile/269811). Forecasting Cytokine Storms with New Predictive Biomarkers. Cancer Discov. 2016 06; 6(6):579-80. PMID: [27261481](//www.ncbi.nlm.nih.gov/pubmed/27261481); PMCID: [PMC4894532](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4894532).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27261481/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  40. Aguayo-Hiraldo P, Arasaratnam R, **Rouce RH**. Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease. Bol Med Hosp Infant Mex. 2016 Jan - Feb; 73(1):31-40. PMID: [29421230](//www.ncbi.nlm.nih.gov/pubmed/29421230).

Citations:  Fields:

Ped Pediatrics

  41. **Rouce RH** , Shaim H, Sekine T, Weber G, Ballard B, Ku S, Barese C, Murali V, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), [Shpall EJ](https://profiles.viictr.org/profile/12582631), Bollard CM, [Rabin KR](https://profiles.viictr.org/profile/265501), [Rezvani K](https://profiles.viictr.org/profile/12583611). The TGF-?/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia. 2016 Apr; 30(4):800-11. PMID: [26621337](//www.ncbi.nlm.nih.gov/pubmed/26621337); PMCID: [PMC4823160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4823160).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26621337/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  42. Rezvani K, **Rouce RH**. The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer. Front Immunol. 2015; 6:578. PMID: [26635792](//www.ncbi.nlm.nih.gov/pubmed/26635792); PMCID: [PMC4648067](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4648067).

Citations:
[116](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26635792/citedby/)
Fields:

All Allergy and Immunology

  43. . The Medical Journal of the Childrenâ€™s Hospital of Mexico. Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease. 2015.

  44. **Rouce RH**. More than Memory: Potential of Adaptive Natural Killer Cells. Biol Blood Marrow Transplant. 2015 Sep; 21(9):1534-6. PMID: [26211986](//www.ncbi.nlm.nih.gov/pubmed/26211986).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26211986/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  45. [Mamonkin M](https://profiles.viictr.org/profile/1826306), **Rouce RH** , Tashiro H, [Brenner MK](https://profiles.viictr.org/profile/268200). A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015 Aug 20; 126(8):983-92. PMID: [26056165](//www.ncbi.nlm.nih.gov/pubmed/26056165); PMCID: [PMC4543231](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4543231).

Citations:
[108](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26056165/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimals

  46. **Rouce RH** , Louis CU, [Heslop HE](https://profiles.viictr.org/profile/269811). Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant. Curr Opin Hematol. 2014 Nov; 21(6):476-81. PMID: [25159713](//www.ncbi.nlm.nih.gov/pubmed/25159713); PMCID: [PMC4257464](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4257464).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25159713/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  47. Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M, Fernandez Curbelo I, Liu E, Muraro PA, [Alousi A](https://profiles.viictr.org/profile/12583841), Stringaris K, [Parmar S](https://profiles.viictr.org/profile/12583446), Shah N, Shaim H, Yvon E, [Molldrem J](https://profiles.viictr.org/profile/12583319), **Rouce R** , [Champlin R](https://profiles.viictr.org/profile/12582508), McNiece I, Mauri C, [Shpall EJ](https://profiles.viictr.org/profile/12582631), [Rezvani K](https://profiles.viictr.org/profile/12583611). Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood. 2014 Sep 25; 124(13):2034-45. PMID: [25051962](//www.ncbi.nlm.nih.gov/pubmed/25051962); PMCID: [PMC4186534](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4186534).

Citations:
[93](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25051962/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  48. Weber G, Caruana I, **Rouce RH** , Barrett AJ, Gerdemann U, [Leen AM](https://profiles.viictr.org/profile/268626), [Rabin KR](https://profiles.viictr.org/profile/265501), Bollard CM. Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy. Clin Cancer Res. 2013 Sep 15; 19(18):5079-91. PMID: [23838315](//www.ncbi.nlm.nih.gov/pubmed/23838315); PMCID: [PMC3778051](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3778051).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23838315/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  49. Moreira A, **Rouce R** , Richardson CJ, Jain S. A premature neonate with leukocytosis. Clin Pediatr (Phila). 2012 Jul; 51(7):692-3. PMID: [21525086](//www.ncbi.nlm.nih.gov/pubmed/21525086).

Citations:  Fields:

Ped Pediatrics

Translation:Humans

  50. . Synopsis of Pediatric Emergency Care. PeePee Publishing, 2010. Oncological Emergencies. 2010.

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 50 publications over 14 distinct years, with a maximum of
7 publications in
2024](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|7&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,14,0,14,29,71,43,57,57,86,57,43,43,86,100&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2010| 1  
2011| 1  
2013| 1  
2014| 2  
2015| 5  
2016| 3  
2017| 4  
2018| 4  
2019| 6  
2020| 4  
2021| 3  
2022| 3  
2023| 6  
2024| 7  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

ROUCE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (171)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [T-Lymphocytes](https://profiles.viictr.org/profile/263702)
  * [Antigens, CD19](https://profiles.viictr.org/profile/260143)
  * [Receptors, Antigen, T-Cell](https://profiles.viictr.org/profile/244627)
  * [Killer Cells, Natural](https://profiles.viictr.org/profile/261504)

[Explore](https://profiles.viictr.org/profile/3010108/198)

_

Co-Authors (70)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [SCHERER, LAUREN](https://profiles.viictr.org/profile/22016570)
  * [HSIEH, EMILY](https://profiles.viictr.org/profile/22016567)
  * [MAMONKIN, MAKSIM](https://profiles.viictr.org/profile/1826306)
  * [STEFFIN, DAVID](https://profiles.viictr.org/profile/14348352)

[Explore](https://profiles.viictr.org/profile/3010108/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [ROONEY, CLIONA](https://profiles.viictr.org/profile/268355)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CHAMPLIN, RICHARD E](https://profiles.viictr.org/profile/12582508)

[Explore](https://profiles.viictr.org/profile/3010108/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [ABU ARJA, MOHAMMAD](https://profiles.viictr.org/profile/51399043)
  * [ALLEN, CARL](https://profiles.viictr.org/profile/270283)
  * [GALLO, MARCO](https://profiles.viictr.org/profile/39966313)
  * [MARGOLIN, JUDITH](https://profiles.viictr.org/profile/268091)
  * [PARSONS, DONALD](https://profiles.viictr.org/profile/265886)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [ECKSTEIN, OLIVE](https://profiles.viictr.org/profile/3010344)
  * [GRAMATGES, MARIA](https://profiles.viictr.org/profile/266349)
  * [KAMDAR, KALA](https://profiles.viictr.org/profile/270282)
  * [PARSONS, DONALD](https://profiles.viictr.org/profile/265886)
  * [SMITH, VALERIA](https://profiles.viictr.org/profile/270003)

_

